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Glycosylation by glycosyltransferase has been the subject of increasing attention because a one-step enzymatic glycosylation is more convenient than chemical glycosylation, which requires tedious steps such as protection-deprotection of the hydroxy groups of the sugar moieties. In addition, the glycosylation of bioactive compounds can enhance their water-solubility, physicochemical stability, and biological half-life [1] [2] [3] [4] [5] [6] [7] .
Docetaxel is a taxane diterpenoid, which shows cytotoxic activity against leukemia cells and inhibitory action against a variety of tumors [8] . It has been recognized as one of the most effective and widely used drugs for the treatment of ovarian, breast, and lung cancers. Despite its effective pharmacological activities, docetaxel has shortcomings such as low solubility in water. We report here the synthesis of a highly water-soluble ester-linked monosaccharide conjugate of docetaxel, i.e., 7-glycolyldocetaxel 2''-O--D-galactopyranoside, and its application to a drug delivery system using immunoliposome targeted with trastuzumab. 7-Glycolyldocetaxel 2''-O--D-galactopyranoside was synthesized by chemo-enzymatic procedures, including stereoselective -galactosylation with lactase ( Figure 1) . First, galactosylation of glycolic acid was catalyzed by lactase. Carboxymethyl -galactopyranoside (1) was benzylated with BnBr/NaH in DMF at room temperature for 12 h, followed by stirring with aqueous KOH to give carboxymethyl 2,3,4,6-tetra-O-benzyl--D-galactopyranoside (2) . The C2' hydroxyl group of docetaxel was selectively protected as a triethylsilyl ether using triethylsilyl chloride (TESCl) and N,Ndiisopropylethylamine in CH 2 Cl 2 affording the 2'-TES ester of docetaxel in 76% yield. The coupling of the 2'-TES ester of docetaxel with 2 in the presence of EDCI/DMAP in CH 2 Cl 2 at room temperature for 12 h gave 3 in 81% yield. Deprotection of both TES and benzyl groups with 10% Pd/C in dioxane/ethanol/0.5% HCl gave 7-glycolyldocetaxel 2''-O--D-galactopyranoside (4) in 62% yield. The water-solubility of 7-glycolyldocetaxel 2''-O--Dgalactopyranoside (4) was 23 M, which was 46-fold higher than that of docetaxel ( Table 1 ). The galactosyl conjugation effectively enhanced the water solubility of doxetaxol. Next, 7-glycolyldocetaxel 2''-O--D-galactopyranoside (4) was applied to a drug delivery system using immunoliposome targeted with trastuzumab. The encapsulation efficiency (EE) and loading efficiency (LE) of docetaxel for liposome were 27% and 1.2%, respectively. On the other hand, EE and LE values of 7-glycolyldocetaxel 2''-O--Dgalactopyranoside (4) 
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Preparation of immunoliposome containing 7-glycolyldocetaxel 2''-O--D-galactopyranoside:
7-Glycolyldocetaxel 2''-O--Dgalactopyranoside was encapsulated in the liposome, to which a maleimide functional group had been introduced by using 1 mol% Mal-PEG-DSPE. SH groups were introduced to trastuzumab by treatment with 2-iminothiolane at a molar ratio of 1:50 in 25 mM HEPES, pH 8.0 containing 140 mM NaCl. The mixture was subsequently incubated for 1 h at room temperature in the dark to give immunoliposome containing 7-glycolyldocetaxel 2''-O--Dgalactopyranoside.
